NO861619A - Renset og trippelklonet hepatitt a virus. - Google Patents

Renset og trippelklonet hepatitt a virus.

Info

Publication number
NO861619A
NO861619A NO861619A NO861619A NO861619A NO 861619 A NO861619 A NO 861619A NO 861619 A NO861619 A NO 861619A NO 861619 A NO861619 A NO 861619A NO 861619 A NO861619 A NO 861619A
Authority
NO
Norway
Prior art keywords
hepatita
clonet
triple
virus
cleaned
Prior art date
Application number
NO861619A
Other languages
English (en)
Other versions
NO169601C (no
NO169601B1 (no
Inventor
Richard J Daemer
Stephen M Feinstone
Robert H Purcell
Ian D Gust
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24615385&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO861619(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Us Health filed Critical Us Health
Publication of NO861619A publication Critical patent/NO861619A/no
Publication of NO169601B1 publication Critical patent/NO169601B1/no
Publication of NO169601C publication Critical patent/NO169601C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/08—Inactivation or attenuation by serial passage of virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32461—Methods of inactivation or attenuation
    • C12N2770/32464—Methods of inactivation or attenuation by serial passage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO86861619A 1984-09-19 1986-04-24 Fremgangsmaate for fremstilling av trippelklonet hepatitt a vaksine NO169601C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/652,067 US4620978A (en) 1982-04-07 1984-09-19 Hepatitis A virus purified and triply cloned

Publications (3)

Publication Number Publication Date
NO861619A true NO861619A (no) 1986-04-24
NO169601B1 NO169601B1 (no) 1992-04-06
NO169601C NO169601C (no) 1992-07-15

Family

ID=24615385

Family Applications (1)

Application Number Title Priority Date Filing Date
NO86861619A NO169601C (no) 1984-09-19 1986-04-24 Fremgangsmaate for fremstilling av trippelklonet hepatitt a vaksine

Country Status (16)

Country Link
US (1) US4620978A (no)
EP (1) EP0196316A4 (no)
JP (1) JPS62500659A (no)
KR (1) KR860700263A (no)
AU (1) AU583306B2 (no)
CA (1) CA1260392A (no)
DK (1) DK227786A (no)
ES (1) ES8701837A1 (no)
FI (1) FI86376C (no)
GR (1) GR852293B (no)
IL (1) IL76417A (no)
NO (1) NO169601C (no)
NZ (1) NZ213513A (no)
PT (1) PT81150B (no)
WO (1) WO1986001826A1 (no)
ZA (1) ZA857134B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894228A (en) * 1982-04-07 1990-01-16 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against hepatitis A virus
USRE37381E1 (en) * 1982-04-07 2001-09-18 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against hepatitis A virus
JPH085804B2 (ja) * 1988-04-28 1996-01-24 財団法人化学及血清療法研究所 Ａ型及びｂ型肝炎混合アジュバントワクチン
US5268292A (en) * 1988-06-27 1993-12-07 Robertson Betty H Reproducible generation of high yields of hepatitis A virus by cell culture
WO1994006446A1 (en) 1992-09-18 1994-03-31 Smithkline Beecham Biologicals, S.A. Hepatitis a virus vaccines
PL178578B1 (pl) * 1993-03-23 2000-05-31 Smithkline Beecham Biolog Zawiesina cząstek 3-0-deacylowanego monofosforylolipidu A i sposób jej wytwarzania oraz kompozycja szczepionki zawierającej antygen w połączeniu z 3-0-deacylowanym monofosforylolipidem A i sposób jej wytwarzania
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US5766906A (en) * 1994-07-11 1998-06-16 The University Of North Carolina At Chapel Hill Hepatitis A virus deletion mutants and vaccine formulations containing the same
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro
US4532215A (en) * 1982-04-07 1985-07-30 The United States Of America As Represented By The Department Of Health And Human Services Isolation of hepatitis A virus strain HM-175

Also Published As

Publication number Publication date
NO169601C (no) 1992-07-15
FI86376B (fi) 1992-05-15
PT81150B (pt) 1987-10-20
IL76417A0 (en) 1986-01-31
FI86376C (fi) 1992-08-25
FI861966A0 (fi) 1986-05-12
NZ213513A (en) 1989-03-29
EP0196316A1 (en) 1986-10-08
CA1260392A (en) 1989-09-26
AU583306B2 (en) 1989-04-27
ES547115A0 (es) 1986-12-01
EP0196316A4 (en) 1987-01-28
ZA857134B (en) 1987-05-27
DK227786D0 (da) 1986-05-16
FI861966A (fi) 1986-05-12
US4620978A (en) 1986-11-04
WO1986001826A1 (en) 1986-03-27
ES8701837A1 (es) 1986-12-01
GR852293B (no) 1986-01-21
KR860700263A (ko) 1986-08-01
JPS62500659A (ja) 1987-03-19
AU4862085A (en) 1986-04-08
PT81150A (en) 1985-10-01
IL76417A (en) 1990-12-23
DK227786A (da) 1986-05-16
NO169601B1 (no) 1992-04-06

Similar Documents

Publication Publication Date Title
NL930085I2 (nl) Benzoylfenylurea.
NO162422C (no) Kampolymerer samt fremstilling og anvendelse derav.
FI861054A (fi) Modulariskt kylningssystem.
NO863646D0 (no) Antivirusmiddel.
NO162299C (no) Silanordning.
MA20508A1 (fr) Caisse
DE3680828D1 (de) Cinnolinderivate.
DE3672872D1 (de) Reinigungsverfahren.
DE3682064D1 (de) Abstandshalter.
NO861619A (no) Renset og trippelklonet hepatitt a virus.
FI850280A0 (fi) Demodulator omfattande en faslaosningskrets.
NO159583C (no) Dreieboggi og skinnekjoeretoey.
NO854968L (no) Alkosymetyleter- og alkoksymetylesterderivater.
DK296687A (da) N-1h-tetrazol-5-yl-2-thiophen-carboxamider, n-1h-tetrazol-5-yl-2-pyrrol-carboxamider og n-1h-tetrazol-5-yl-2-furan-carboxamider
ES284271Y (es) Una freidora
DK488185D0 (da) N6-benzopyrano- og benzothiopyranoadenosiner
NO168193C (no) Forskalingssten
TR23713A (tr) Suebstituye edilmis tiouereler,izotiouereler ve korbadiimetiller
FR2572448B1 (fr) Echafaudage.
IT1206705B (it) Preparazioni. 1-fenossi-3-idrossiindolil-alchilammino-3-propanoli e loro
NO892248L (no) Alkoksymetyleter- og alkoksymetylesterderivater.
ATE67835T1 (de) Pulsierende verbrennungseinrichtung.
IT8434606V0 (it) A b c
ATE39924T1 (de) Dihydropyridine.
IT8423096V0 (it) Soffiatore modulare.

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
MK1K Patent expired